Davis Select US Equity Aktie - DUSA

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

43,02

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

37,50 52-Wochen-Bereich 46,24

Handelsende

43,02

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

52.483

Finanzvolumen

VWAP

DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Ca

WILMINGTON, Mass., Feb. 26 /PRNewswire/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its 2009 corporate highlights and year...

DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

WILMINGTON, Mass., Feb. 2 PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (NASDAQ:DUSA), a specialty pharmaceutical company focused...

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a dermatology company that is developing and...

DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

Q3 Domestic PDT revenues up 32% year over year; Q3 Non-GAAP loss improves 86% year over year to ($0.2) million WILMINGTON, Mass., Nov. 6...

DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units

WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused...

DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America

Second Consecutive Year DUSA Has Been Recognized WILMINGTON, Mass., Oct. 21 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R...

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

WILMINGTON, Mass., Sept. 2 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA), a dermatology company that is developing and...

DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results

Q2 Domestic PDT revenues up 24% year over year; Kerastick margins reach a record high of 85% WILMINGTON, Mass., Aug. 11 /PRNewswire-FirstCall/...

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA) announces that its corporate highlights and...

Amex to Trade Options on Nine Securities

Amex to Trade Options on Nine Securities NEW YORK, March 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-2.01	-4.46369087275	45.03	45.25	42.22	68332	43.3471759	SP
4	-2.47	-5.42976478347	45.49	46.24	42.22	53324	44.63349519	SP
12	-0.92	-2.09376422394	43.94	46.24	41.77	52483	44.18188317	SP
26	3.205	8.04973000126	39.815	46.24	38.66	38972	43.82869818	SP
52	4.17	10.7335907336	38.85	46.24	37.5	32891	42.19865204	SP
156	11.69	37.3124800511	31.33	46.24	24.67	27309	34.90055704	SP
260	10.3	31.4792176039	32.72	46.24	24.67	25127	34.85829632	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CZTACheckpoint Therapeutics Inc	3,575 € (56,11%)	7,5k
RTCRealtech AG	2,40 € (38,73%)	136,02k
L7C2Windfall Geotek Inc	0,0145 € (26,09%)	5,02k
36GGBM Resources Limited	0,005 € (25,00%)	15,05k
E3O1Nexoptic Technology Corp	0,0105 € (23,53%)	2,25k
ERWEERWE Immobilien AG	0,232 € (-22,67%)	800
TO1Collective Metals Inc	0,0302 € (-19,68%)	160
R1EAEV Resources Ltd	0,002 € (-16,67%)	80k
UH7ATennant Minerals NL	0,0075 € (-16,67%)	7,69k
AMIMedondo Holding AG	0,404 € (-16,53%)	200
E3BEutelsat Communications	6,475 € (16,67%)	444,46k
TKAThyssenkrupp AG	9,478 € (4,89%)	384,07k
FMKEcograf Limited	0,082 € (12,33%)	289,02k
RKM0Vault Minerals Ltd	0,242 € (1,68%)	264,97k
LHADeutsche Lufthansa AG	7,958 € (-0,40%)	187,03k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Davis Select US Equity (DUSA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

DUSA Neueste Nachrichten

DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Ca

DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units

DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

Amex to Trade Options on Nine Securities

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Davis Select US Equity (DUSA) Börsenkurse

Davis Select US Equity (DUSA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

DUSA Neueste Nachrichten

DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Ca

DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units

DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

Amex to Trade Options on Nine Securities

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen